Veterinary Medicines

Versifel FeLV, suspension for injection

Authorised
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
Download as PDF

Product identification

Medicine name:
Versifel FeLV, suspension for injection
Versifel FeLV ενέσιμο εναιώρημα για γάτες
Active substance:
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
    8.10
    log2 geometric mean titre
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:
  • (ID2): 1 Box with 25 Bottle (Glass) with 1 Dose (25 Dose)
  • (ID1): 1 Box with 10 Bottle (Glass) with 1 Dose (10 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • CY00410V
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0254/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 20/10/2023
Download
Greek (PDF)
Published on: 4/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."